The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures - II. Motor seizure

By Abdul-Ghani A.-S.   Attwell P.J.E.   Bradford H.F.  

European Journal of Pharmacology, Vol. 326, Iss. 1, 1997-05 ,pp. : 7-14

Elsevier

Access to resources Recommend Favorite

Weak anticonvulsant effects of two novel glycine B receptor antagonists in the amygdala-kindling model in rats

By Wlaz P.   Loscher W.  

European Journal of Pharmacology, Vol. 342, Iss. 1, 1998-01 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat

By Kodama M.   Yamada N.   Sato K.   Kitamura Y.   Koyama F.   Sato T.   Morimoto K.   Kuroda S.  

European Journal of Pharmacology, Vol. 374, Iss. 1, 1999-06 ,pp. : 11-19

Elsevier

Access to resources Recommend Favorite

BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy

By Morimoto K.   Sato H.   Sato K.   Sato S.   Norihito Yamada  

European Journal of Pharmacology, Vol. 339, Iss. 1, 1997-11 ,pp. : 11-15

Elsevier

Access to resources Recommend Favorite

D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures

By Tober C.   Rostock A.   Rundfeldt C.   Bartsch R.  

European Journal of Pharmacology, Vol. 303, Iss. 3, 1996-05 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite